Loti 5 Rituximab Biosimilar/origjinator
| Contracted Institution | Ministry of Health | ||||||||||||
| Tenderer Institution | Ministry of Health | ||||||||||||
| Tender object |
B4-Blerje barna antineoplastike dhe immunomodulatore, si dhe gjaku dhe organet formuese të gjakut. - Loti 5 Rituximab Biosimilar/origjinator Burimi i Financimit: Buxheti i shtetit. |
||||||||||||
| Reference No. | REF-58377-05-18-2020 | ||||||||||||
| Estimated / Ceiling Value ALL without VAT | 6 296 011,00 | ||||||||||||
| Type of Contract | |||||||||||||
| Procurement Method | Open Procedure above the high monetary limit | ||||||||||||
| Stage Procedure | Announced the Winner | ||||||||||||
| Tender Publication Date | 19-05-2020 | ||||||||||||
| Last date of Submitted Documents | 03-07-2020 | ||||||||||||
| Tender Held Date | 03-07-2020 | ||||||||||||
| No. of Bidders | |||||||||||||
| Bidders | EdnaFarma | ||||||||||||
| Successful Bidder /Supplier / Provider |
|
||||||||||||
| The winning bid ALL without vat | 6 262 800,00 | ||||||||||||
| Bidder Announcement date | 19-08-2020 | ||||||||||||
| Award and Contract Amount ALL with VAT | |||||||||||||
| Contract date | |||||||||||||
| Planned Milestones of Contract / Start and End Date | Kontratat mund te lidhen nga AK perfituese brenda afatit 24 muaj nga data e neshkrimit te MK nga palet, për sejcilin lot. | ||||||||||||
| Renewal Contract Additional Value (ALL with VAT) |
|
||||||||||||
| Appeals | Nuk ka pasur ankesa dhe skualifikime. | ||||||||||||
| Cancellation reason | |||||||||||||
| Additions | |||||||||||||
| Transaction / Actual Spending |
Monitor treasury transaction for EDNA - FARMA SHPK viti 2014 Monitor treasury transaction for EDNA - FARMA SHPK viti 2015-2018 Monitor treasury transaction for EDNA - FARMA SHPK viti 2019-2020 |
||||||||||||
| Public Announcement Bulletin |
Contracts signed under the Framework Agreement Ministria e Shëndetësisë REF-58377-05-18-2020
|